XML 43 R28.htm IDEA: XBRL DOCUMENT v3.20.1
FAIR VALUE MEASUREMENTS (Tables)
3 Months Ended
Mar. 25, 2020
Fair Value Disclosures [Abstract]  
Schedule of Cash and Cash Equivalents
The following tables summarize our cash, cash equivalents and marketable securities by significant investment categories as of March 25, 2020 and December 25, 2019:
 
 
March 25, 2020
 
 
Cost Basis

 
 Gross Unrealized Gains

 
 Gross Unrealized Losses

 
 Fair Value

 
 Cash and Cash Equivalents

 
Marketable Securities

Cash
$
87,806

 
$

 
$

 
$
87,806

 
$
87,806

 
$

Level 1:
 
 
 
 
 
 
 
 
 
 
 
 
Money market funds

 

 

 

 

 

 
Mutual funds
16,707

 

 
(284
)
 
16,423

 

 
16,423

Total
$
104,513

 
$

 
$
(284
)
 
$
104,229

 
$
87,806

 
$
16,423

 
 
December 25, 2019
 
 
Cost Basis

 
 Gross Unrealized Gains

 
 Gross Unrealized Losses

 
 Fair Value

 
 Cash and Cash Equivalents

 
Marketable Securities

Cash
$
32,094

 
$

 
$

 
$
32,094

 
$
32,094

 
$

Level 1:
 
 
 
 
 
 
 
 
 
 
 
 
Money market funds
5,005

 

 

 
5,005

 
5,005

 

 
Mutual funds
36,436

 
72

 

 
36,508

 

 
36,508

Total
$
73,535

 
$
72

 
$

 
$
73,607

 
$
37,099

 
$
36,508


Schedule of Other Income From Available for Sale Securities
A summary of other income from equity securities recognized during the thirteen weeks ended March 25, 2020 and March 27, 2019 is as follows:
 
 
Thirteen Weeks Ended
 
 
March 25
2020

 
March 27
2019

Equity securities:
 
 
 
 
Dividend income
$
184

 
$
392

 
Interest income

 

 
Realized gain (loss) on sale of investments
79

 
(14
)
 
Unrealized gain (loss) on equity securities
(356
)
 
157

Total
$
(93
)
 
$
535


Schedule of Available-for-sale Securities and Gross Realized Gains and Losses
A summary of equity securities sold and gross realized gains and losses recognized during the thirteen weeks ended March 25, 2020 and March 27, 2019 is as follows:
 
 
Thirteen Weeks Ended
 
 
March 25
2020

 
March 27
2019

Equity securities:
 
 
 
 
Gross proceeds from sales and redemptions
$
20,000

 
$
15,000

 
Cost basis of sales and redemptions
19,921

 
15,014

 
Gross realized gains included in net income (loss)
79

 

 
Gross realized losses included in net income (loss)

 
(14
)